1 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update JOINT RCRIM and CG Session CTLAB Message Pharmacogenomics Results Overview.

Slides:

Advertisements

Similar presentations

Monika Kawohl Principal Statistical Programmer Accovion

Advertisements

IHE Cardiology Implantable Cardiac Device Interrogation (ICDI) Profile Nicholas Steblay 2/3/2006.

Cardiology Special Interest Group Presentation to Technical Steering Committee September 12, 2005.

Clinical Genomics Domain Analysis Model Joyce Hernandez Mukesh Sharma.

© 2011 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.

HL7 Version 3 Adverse Event Assessment CMET Specification Jennifer Neat Project Leader, City of Hope August 7, 2007.

HL7 ICSR DSTU Update FDA progress since last working group meeting: –Completed mapping to all FDA AE programs, data collection forms and E2B –Completed.

HL7 Version 3 Laboratory Result-based Adverse Event Assessment Message Specifications RCRIM Technical Meeting September 18, 2007 Jennifer Neat Project.

HL7 January Working Group Meeting

HL7 XML ITS R1.1 Charlie McCay

1 HL7 Jan 2007 Working Group MeetingsPharmacogenomics Update RCRIM TC Philip M. Pochon Covance Enterprise Architecture.

RPS 2 Project Update Mary Ann Slack, FDA Presentation to HL7 RCRIM January 12, 2009.

1 Intermountain Healthcare Clinical Genetics Institute Marc S. Williams, M.D. Director Grant M. Wood Senior IT Strategist Introduction to HL7 Clinical.

Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM.

2006 European Interchange: RCRIM Meeting RCRIM Vocab & CDISC CT Initiative: Overview and Update Bron Kisler, CDISC Terminology Team Lead.

CDISC Content to Message HL7 Development Overview Jason Rock

Presentation to RCRIM San Antonio, TX January 15, 2008 Meredith Nahm, M.S. CV/TB Global Data Standards Efforts Therapeutic Area Data Standards: Cardiovascular.

HL7 Working Group Meeting Orlando, Florida 14 January

HL7 Clinical Genomics and Structured Documents Work Groups CDA Implementation Guide: Genetic Testing Report DRAFT PROPOSAL Amnon Shabo (Shvo), PhD

CDISC-HL7 Project Update Armando Oliva, M.D. FDA Sponsor HL7 Workgroup Meeting January 14, 2008 San Antonio TX.

Proposed Revised Mission of the Conformance Sig Current Mission Statement –The SIG Conformance will provide mechanisms for : 1. Specification of conformance.

HL7 Clinical Genomics – RIM Constraining Issues May 2008 The HL7 Clinical Genomics SIG Amnon Shabo (Shvo), PhD HL7 Clinical Genomics SIG Co-chair and Modeling.

HL7 Clinical-Genomics SIG: Tissue-Typing Models and a Reusable Genotype Module HL7 V3 Compliant HL7 Clinical-Genomics SIG Facilitator Amnon Shabo (Shvo)

HL7 EHR SIG New Projects- Tentative Gary Dickinson 5 May 2004.

Presentation for HL7 RCRIM and Clinical Genomics SIG HL7 Working Group Meeting San Diego, CA 21Jan2004.

San Antonio – Todd Cooper Chair, ISO/IEEE 11073; Co-Chair HL7 DEV WG HL7 DEV WG ISO TC215 WG7 IEEE EMBS Health Informatics – Devices Update.

Regulated Product Submissions R1 Overview January 12 th HL7 WGM Jason Rock

HL7 v3 Clinical Genomics – Overview

Clinical Genomics Sub-team Sub-team is one of three that evolved out of the DIA Pharmacogenomics Standards Workshop. Workshop was product of collaborative.

BRIDG Overview Clinical Observation Interoperability March 18, 2008.

LRI Validation Suite Meeting August 16, Agenda Review of LRI Validation Suite Charter/Overview Acquiring test data update Review of proposed test.

IHIC 2011 – Orlando, FL Amnon Shabo (Shvo), PhD HL7 Clinical Genomics WG Co-chair and Modeling Facilitator HL7 Structured Documents WG.

Name ____________________ Date ___________ Period ____.

May 2014 Work Group Meeting Clinical Genomics Minutes Pheonix, AZ.

Archetypes in HL7 2.x Archetypes/Structure in HL7 Version 2.x Andrew McIntyre Medical-Objects 10 th HL7 Australia Conference,

Update on CDISC Terminology Activities RCRIM Vocab Session (Q4) 14 January 2009, Orlando Bron Kisler (CDISC)

Hl7 and the Clinical Genomics Work Group

C-CDA Constraints FACA - Strategy Discussion June 23, 2014 Mark Roche, MD.

Clinical Genomics Work Group (HL7) Mukesh Sharma Washington University in St. Louis.

HL7 Clinical Genomics – Implementation Roadmap The HL7 Clinical Genomics SIG Amnon Shabo (Shvo), PhD HL7 Clinical Genomics SIG Co-chair and Modeling Facilitator.

 BRIDG R3.0.2 was released in August 2010  The BRIDG Model passed the initial ISO Joint Initiative Council ballot as a Draft International Standard (DIS)

1 Health Level Seven (HL7) Report Out Population Science and Structured Documents Workgroup (SDWG) Riki Ohira September 22, 2011.

Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.

Standards Analysis Summary vMR – Pros Designed for computability Compact Wire Format Aligned with HeD Efforts – Cons Limited Vendor Adoption thus far Represents.

Clinical Genomics Work Group (HL7) Mukesh Sharma Washington University in St. Louis June 16, 2011.

1 RCRIM Vocab-BRIDG Session Wednesday, Session Q2 19 September 2007.

Clinical Genomics Joint with RCRIM Amnon Shabo Joyce Hernandez Mukesh Sharma.

Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting March 12, 2012.

RCRIM Projects: Protocol Representation and CDISC Message(s) January 2007.

RCRIM Off-cycle Meeting Barbara Tardiff, Randy Levin and Ed Tripp, co-chairs.

Briefing: HL7 Working Group Meeting Update for the VCDE Community Dianne M. Reeves Associate Director, Biomedical Data Standards NCI CBIIT VCDE Meeting.

HL7 v3 Clinical Genomics – Overview The HL7 Clinical Genomics Work Group Prepared by Amnon Shabo (Shvo), PhD HL7 Clinical Genomics WG Co-chair and Modeling.

Regulated Product Submission HL7 Update Wednesday January 10 th, 2007 Jason Rock

HL7 Clinical-Genomics SIG: Tissue-Typing Models and a Reusable Genotype Module HL7 V3 Compliant IBM Research Lab in Haifa together with Hadassah University.

LRI Validation Suite Meeting Prototype Tool Demonstration December 20th, 2011.

BRIDG Imaging Project Nov. 25th, Agenda Project Goals & Objectives Imaging Projects of interest Rationale for aligning with BRIDG Principles on.

1 CDISC HL7 Project FDA Perspective Armando Oliva, M.D. Office of Critical Path Programs FDA.

Ballot Reconciliation Meeting Notes 1.Ballot Tally & Reconciliation a.CTLaboratory Release 3 / HL7 Version 3 Standard: Periodic Reporting of Clinical Trial.

Standards Analysis Summary vMR – Pros Designed for computability Compact Wire Format Aligned with HeD Efforts – Cons Limited Vendor Adoption thus far Represents.

Updates on CDISC Activities

BRIDG Update RCRIM Working Group Meeting Rio de Janeiro 17 May 2010 Julie Evans Senior Director, Technical Services, CDISC Wendy Ver Hoef Senior Analyst,

Information Representation Working Group WG Meeting September 5, 2008.

© CDISC 2015 Paul Houston CDISC Europe Foundation Head of European Operations 1 CTR 2 Protocol Representation Implementation Model Clinical Trial Registration.

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.

HL7 Clinical Genomics – Domain Information Model The HL7 Clinical Genomics Work Group Prepared by Amnon Shabo (Shvo), PhD HL7 Clinical Genomics WG Co-chair.

Paul Houston CDISC Europe Foundation Head of European Operations

Structured Data Capture (SDC)

STDMIG-PGx Implementation in Clinical Trials Using Legacy PGx DB

Structured Data Capture (SDC)

HL7 Working Group Meeting RCRIM Technical Committee

Presentation transcript:

1 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update JOINT RCRIM and CG Session CTLAB Message Pharmacogenomics Results Overview

2 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update Joint RCRIM and CG AGENDA PGx History CTLAB Overview Overview of Genetic Variation Model Overview of Gene Expression Domain Analysis Model Next Steps PGx CTLAB Rel 2 Status and Normative path

3 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update Pharmacogenomics History HL7 Clinical Genomics WG Established as a SIG in 2003 Includes members from clinical practice and clinical research Focus on V2 and V3 (Common Message Elements [CMET]) genetic and genomics data models V3 Genetic Models Single Gene (Genetic Locus) CMET Draft Standard for Trial Use – May 2005 (Revised May 2006) Multiple Gene (Genetic Loci) CMET Draft Standard for Trial Use – Jan 2007 Unified Full Genetic Variation CMET Draft Standard for Trial Use – Jan 2008 Normative – Jan 2010

4 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update Pharmacogenomics History (cont.) Genetic Variation V2 message Developed for clinical practice to carry findings from a lab to a physician, genetic councilor, etc. Subset of full V3 model, focus on interpretive, not raw (sequence) data Genetic Variation V3 Reduced CMET Companion to V2 message HL7 Clinical Statement compliant (payload for O&O Lab) Gene Expression Model Intended for V2 and V3 implementation Domain Analysis Model balloted Sept 2009

5 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update CTLAB Overview Based on CDISC LAB Model First CDISC model converted to HL7 Based on CDISC version 1.0.1, but fully implements version 1.1 Designed for bulk (daily, weekly, monthly) transmission of lab test results from a lab to a clinical trial sponsor HL7 History Passed DSTU Ballot in October 2003 Passed Normative Ballot in May 2005 Implementation Guide Balloted Jan 2006 ISO Standard in August 2007

6 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update Genetic Variation Overview Presented by Amnon

7 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update Pharmacogenomics Directions V3 Genetic Variation Updated IG for CMET by May 2010 Additions to Support Complex Disease Genotyping. Extend Domain Analysis Model for Genetic Variation, Date TBD V2 Genetic Variation Additions to Support Complex Disease Genotyping. Gene Expression V2 IG and V3 CMET expected by May 2010 Re-ballot enhanced GE DAM by May 2010 Specimen Handling Initial work started – mapping to NCI, LOINC and SNOMED

8 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update CTLABR2 Structure and Status Based on CTLAB Version 1 Designed for bulk (daily, weekly, monthly) transmission of genetic testing results from a lab to a clinical trial sponsor Designed to carry genetic raw and low granularity data under an SDTM suite of domains (as with ECG data) Additions to Core Model Consent to Genotype Act Some Specimen Handling (Collected to DNA/RNA) Call for the Genetic Variation CMET(s) Passed First DSTU Ballot May 2006 Modified May 2007 for multigene CMET Tested with Drug Metabolism and Cancer Gene Data

9 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update CTLABR2: Get to Normative Required Upgrade CMET Call for Normative Genetic Variation CMET Use genomic choice box currently consist of GV future includes GE Add Genetic Specific Content to BRIDG (CTLAB already there) Complete vocabulary development and binding for non-CMET elements Desirable Harmonize Specimen Handling with O&O Lab CMET Follow Ups Upgrade Implementation Guide Longer Term Upgrade for Gene Expression CMET(s) Upgrade for Microorganism Genotyping (Viral and Bacterial) Upgrade or clone/modify to allow animal subjects for CDISC SEND support